10-QPeriod: Q1 FY2012

UNITEDHEALTH GROUP INC Quarterly Report for Q1 Ended Mar 31, 2012

Filed May 3, 2012For Securities:UNH

Summary

UnitedHealth Group's first quarter 2012 report shows solid revenue growth, driven by its UnitedHealthcare and Optum segments, with total revenues increasing by 7% year-over-year to $27.3 billion. Net earnings also saw a modest increase of 3% to $1.39 billion, resulting in diluted earnings per share of $1.31, up 7% from the prior year. The company experienced significant membership growth in its Medicare Advantage and Medicaid offerings, partially offset by a decline in Medicare Part D stand-alone membership. Optum's revenue grew by 8%, though its operating profit saw a decline due to investments in infrastructure and a decrease in Medicare Part D prescription volumes. The company's balance sheet remains strong, with total assets growing to $72.7 billion and a healthy cash position. Acquisitions continue to be a key focus, with $1.9 billion spent in the quarter. Despite ongoing regulatory uncertainties, particularly related to the Affordable Care Act, UnitedHealth Group demonstrates resilience and strategic execution.

Financial Statements
Beta
Revenue$27.28B
Cost of Revenue$634.00M
Gross Profit$26.65B
SG&A Expenses$4.10B
Operating Expenses$24.96B
Operating Income$2.32B
Interest Expense$148.00M
Net Income$1.39B
EPS (Basic)$1.34
EPS (Diluted)$1.31
Shares Outstanding (Basic)1.04B
Shares Outstanding (Diluted)1.06B

Key Highlights

  • 1Total revenues increased by 7% to $27.3 billion in Q1 2012 compared to Q1 2011.
  • 2Net earnings grew by 3% to $1.39 billion, with diluted EPS rising 7% to $1.31.
  • 3UnitedHealthcare segment revenues increased by 7%, driven by growth in individuals served and commercial premium rate increases.
  • 4Optum segment revenues increased by 8%, though operating earnings decreased due to strategic investments and lower Medicare Part D volumes.
  • 5Medical enrollment in UnitedHealthcare grew by 1.6 million people, with notable increases in Medicare Advantage and Medicaid.
  • 6The company repurchased approximately $991 million of its common stock during the quarter.
  • 7Acquisitions remained a significant use of cash, with $1.9 billion spent in the first quarter of 2012.

Frequently Asked Questions

Revenue growth was primarily driven by an increase in the number of individuals served across both the UnitedHealthcare and Optum segments, coupled with commercial premium rate increases reflecting anticipated medical cost trends. UnitedHealthcare's revenue grew 7%, while Optum's revenue saw an 8% increase.

Medical costs increased by 6% year-over-year, primarily due to rising costs per service for health system use, especially hospital prices. However, this was partially offset by a favorable medical cost development of $530 million related to prior fiscal years, attributed to lower-than-expected health system utilization.

The company acknowledges significant regulatory uncertainties, especially regarding the ACA. While it creates opportunities for expanded coverage, potential impacts from court proceedings, congressional action, and the phasing in of new programs (like premium rebates and industry fees) introduce risks and require careful management and adjustments to pricing and operations.

The company generated $3.59 billion in cash from operating activities. Key uses of cash included $1.9 billion for acquisitions, $991 million for common stock repurchases, and $168 million for dividends paid. The company also raised $1 billion in long-term debt during the quarter.